AURORA

Topic of Study: Gastrointestinal Disease

Sponsor: Tobira Therapeutics

Principal Investigator: Paul Thuluvath, M.D., FRCP, 410-332-9356

Research Coordinator: Sung Cho, 410-576-5389

For More Information: scho@mdmercy.com

Coordinated Through: The Institute for Digestive Health and Liver Disease

This study is a phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of cenicriviroc for the treatment of liver fibrosis in adult subjects with nonalcoholic steatohepatitis. (AURORA)